Position in MRNA
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$4,647,891
-$240,459 QoQ
Shares Held
66,370
-60.0% QoQ
Ownership
0.017%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#158
of 758 holders
Holding Since
Jun 2020
21 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in MRNA Over Time
Shares Held
Position Value (USD)
Derivatives in MRNA
reported options exposure · as of Dec 31, 2025CallValue
$0
CallShares
0
PutValue
$29,490,000
PutShares
1,000,000
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Jun 30, 2026NATIXIS holds $65,699,213 across 42 Biotechnology names. MRNA ranks #4 (7.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
59,095 | $29,354,259 | |
| 2 | CORT |
Corcept Therapeutics Inc
|
109,905 | $9,556,239 | |
| 3 | EXEL |
Exelixis, Inc.
|
121,041 | $6,585,840 | |
| 4 | MRNA |
Moderna, Inc.
This page
|
66,370 | $4,647,891 | |
| 5 | REGN |
Regeneron Pharmaceuticals, Inc.
|
6,599 | $4,114,740 | |
| 6 | CAI |
Caris Life Sciences, Inc.
|
124,716 | $2,222,439 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
8,467 | $1,585,699 | |
| 8 | PTGX |
Protagonist Therapeutics, Inc
|
7,776 | $953,182 |
All Filings in MRNA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,647,891 | 66,370 | Shares | Sole | 2026-08-13 | |
| 2025-12-31 | $29,490,000 | 1,000,000 | Put | Sole | 2026-02-13 | |
| 2025-12-31 | $4,888,350 | 165,763 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $41,328,000 | 1,600,000 | Put | Sole | 2025-11-14 | |
| 2025-06-30 | $2,734,472 | 99,111 | Shares | Sole | 2025-08-13 | |
| 2025-06-30 | $16,554,000 | 600,000 | Put | Sole | 2025-08-13 | |
| 2024-12-31 | $4,738,706 | 113,966 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $4,277,988 | 64,013 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $29,308,212 | 246,806 | Shares | Defined | 2024-08-13 | |
| 2023-12-31 | $4,949,527 | 49,769 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $322,264 | 3,120 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $1,283,526 | 10,564 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $494,527 | 3,220 | Shares | Defined | 2023-05-12 | |
| 2022-09-30 | $18,225,163 | 154,124 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $33,198,911 | 232,404 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $9,677,739 | 56,181 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $43,398,324 | 170,873 | Shares | Defined | 2022-02-14 | |
| 2021-09-30 | $125,343,513 | 325,686 | Shares | Defined | 2021-11-12 | |
| 2021-06-30 | $59,806,404 | 254,517 | Shares | Defined | 2021-08-13 | |
| 2021-03-31 | $95,642,475 | 730,374 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $40,733,793 | 389,909 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $5,482,629 | 77,493 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $16,224,197 | 252,674 | Shares | Sole | 2020-08-13 | |
| No filing history on record for this holder in this stock. | ||||||